SAN DIEGO, Nov. 9, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced that Dr. Yuichi Iwaki, President and Chief Executive Officer of MediciNova, together with Dr. Kirk Johnson, Chief Scientific Officer of MediciNova, will present a company overview at the Lazard Capital Markets Healthcare Conference on Wednesday, November 16, 2011 at 11:00 a.m. Eastern Time. The conference is being held at The Pierre Hotel in New York City.
